Clinical Trial Update: Effects of Low-dose Ketamine as an Adjunct to Propofol-based Anesthesia for Electroconvulsive Therapy [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating low-dose ketamine as an adjunct to propofol anesthesia for electroconvulsive therapy in depressive disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Depressive Disorder

Drugs mentioned

• Ketamine (ketamine)
• PROPOFOL (Propofol)

Snippet

Sponsor: University of Alberta | Conditions: Depressive Disorder | Phase 4 | Status: COMPLETED